Increased levels of anti-PfCSP antibodies in post-pubertal females versus males immunized with PfSPZ Vaccine does not translate into increased protective efficacy by Natasha KC, L. W. Preston Church, Pouria Riyahi, Sumana Chakravarty, Robert A. Seder, Judith E. Epstein, Kirsten E. Lyke, Benjamin Mordmüller, Benjamin Mordmüller, Peter G. Kremsner, Peter G. Kremsner, Mahamadou S. Sissoko, Sara Healy, Patrick E. Duffy, Said A. Jongo, Vicente Urbano Nsue Ndong Nchama, Salim Abdulla, Maxmillian Mpina, Maxmillian Mpina, Maxmillian Mpina, Sodiomon B. Sirima, Sodiomon B. Sirima, Matthew B. Laurens, Laura C. Steinhardt, Martina Oneko, MingLin Li, Tooba Murshedkar, Peter F. Billingsley, B. Kim Lee Sim, Thomas L. Richie, Stephen L. Hoffman

Get full text

Visceral Leishmaniasis in Immunocompetent Hosts in Brescia: A Case Series and Analysis of Cytokine Cascade by Alice Mulè, Verena Crosato, Douglas Byron Kuhns, Luisa Lorenzi, Claudia Chirico, Giovanni Maifredi, Luigi D. Notarangelo, Francesco Castelli, Lina R. Tomasoni

Get full text

Screening of primary gp120 immunogens to formulate the next generation polyvalent DNA prime-protein boost HIV-1 vaccines by Shixia Wang, Te-hui Chou, Anthony Hackett, Veronica Efros, Yan Wang, Dong Han, Aaron Wallace, Yuxin Chen, Guangnan Hu, Shuying Liu, Paul Clapham, James Arthos, David Montefiori, Shan Lu

Get full text

Unveiling the Power of Anticancer Drug Screening: A Clinical Case Study Comparing the Effectiveness of Hollow Fiber Assay Microtube Array Membrane (MTAM-HFA) in Breast Cancer Patie... by Shih-Hsin Tu, Wan-Ting Huang, Chee Ho Chew, Amanda Lin Chen, Shou-Tung Chen, Jin-Hua Chen, Yi-Chen Hsieh, Chien-Chung Chen

Get full text

Predictive capabilities of baseline radiological findings for early and late disease outcomes within sensitive and multi-drug resistant tuberculosis cases by Gabriel Rosenfeld, Andrei Gabrielian, Darrell Hurt, Alex Rosenthal

“…Method: This is a retrospective study analyzing cases from the NIH/NIAID supported TB Portals database, a large, trans-national, multi-site cohort of primarily drug-resistant tuberculosis patients. …”
Get full text

Vaccination is the most effective and best way to avoid the disease of COVID‐19 by Hadi Lotfi, Mina G. Mazar, Negar M. H. Ei, Mostafa Fahim, Nafiseh S. Yazdi

“…BNT162b2 and mRNA‐1273 vaccines were made by BioNTech/Pfizer/Fosun Pharma group and Moderna/NIAID group, respectively, which are considered as types of RNA vaccines. …”
Get full text

Public health and economic impact of switching from a trivalent to a quadrivalent inactivated influenza vaccine in Mexico by Guillermo M. Ruiz-Palacios, John H. Beigel, Maria Lourdes Guerrero, Lucile Bellier, Ramiro Tamayo, Patricia Cervantes, Fabián P. Alvarez, Arturo Galindo-Fraga, Felipe Aguilar-Ituarte, Juan Guillermo Lopez

Get full text

Endosomal mTORC2 Is Required for Phosphoinositide-Dependent AKT Activation in Platelet-Derived Growth Factor-Stimulated Glioma Cells by Suree Kim, Sukyeong Heo, Joseph Brzostowski, Dongmin Kang

Get full text

Evaluating the predictive utility of patient‐oriented scoring of atopic dermatitis (PO‐SCORAD) versus Patient‐Oriented Eczema Measure (POEM) for peanut sensitivity in patients with... by Sara Bilimoria, Kachiu Lee, Peter Lio

“…Abstract Background Current Guidelines from the National Institute of Allergy and Infectious Disease (NIAID) are based on the Learning Early About Peanut Allergy Study (LEAP Study) results and recommend early introduction of peanuts to children with atopic dermatitis (AD) depending on their disease severity. …”
Get full text

Responders to low-dose ATG induce CD4+ T cell exhaustion in type 1 diabetes by Laura M. Jacobsen, Kirsten Diggins, Lori Blanchfield, James McNichols, Daniel J. Perry, Jason Brant, Xiaoru Dong, Rhonda Bacher, Vivian H. Gersuk, Desmond A. Schatz, Mark A. Atkinson, Clayton E. Mathews, Michael J. Haller, S. Alice Long, Peter S. Linsley, Todd M. Brusko

“…Helmsley Charitable Trust (2019PG-T1D011), the NIH (R01 DK106191 Supplement, K08 DK128628), NIH TrialNet (U01 DK085461), and the NIH NIAID (P01 AI042288).…”
Get full text

Cryptococcus and Cryptococcosis: Updates on Pathogenesis, Diagnosis and Treatment Strategies for HIV Infected Patients by Zainab Bandalizadeh, Mojtaba Seyedmousavi, Willem J.G. Melchers, Mahmoud Fami Zaghrami, Ali Asghar Mostaed Rostami, Tahereh Shokohi

Get full text

Towards a Sustainable One Health Approach to Crimean–Congo Hemorrhagic Fever Prevention: Focus Areas and Gaps in Knowledge by Teresa E. Sorvillo, Sergio E. Rodriguez, Peter Hudson, Megan Carey, Luis L. Rodriguez, Christina F. Spiropoulou, Brian H. Bird, Jessica R. Spengler, Dennis A. Bente

“…Crimean–Congo hemorrhagic fever virus (CCHFV) infection is identified in the 2018 World Health Organization Research and Development Blueprint and the National Institute of Allergy and Infectious Diseases (NIH/NIAID) priority A list due to its high risk to public health and national security. …”
Get full text

<i>Mastomys natalensis</i> Has a Cellular Immune Response Profile Distinct from Laboratory Mice by Tsing-Lee Tang-Huau, Kyle Rosenke, Kimberly Meade-White, Aaron Carmody, Brian J. Smith, Catharine M. Bosio, Michael A. Jarvis, Heinz Feldmann

Get full text

Reactivation of Coccidioidomycosis in a Mouse Model of Asymptomatic Controlled Disease by Lisa F. Shubitz, Daniel A. Powell, Sharon M. Dial, Christine D. Butkiewicz, Hien T. Trinh, Amy P. Hsu, Adam Buntzman, Jeffrey A. Frelinger, John N. Galgiani

Get full text

Mucosal vaccines for SARS-CoV-2: scientific gaps and opportunities—workshop report by Jane M. Knisely, Lucas E. Buyon, Rebecca Mandt, Rebecca Farkas, Shobana Balasingam, Karin Bok, Ursula J. Buchholz, M. Patricia D’Souza, Jennifer L. Gordon, Deborah F. L. King, Tung T. Le, Wolfgang W. Leitner, Robert A. Seder, Alkis Togias, Stig Tollefsen, David W. Vaughn, Daniel N. Wolfe, Kimberly L. Taylor, Anthony S. Fauci

“…On November 7th and 8th, 2022, The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), The Coalition for Epidemic Preparedness Innovation (CEPI), The Bill & Melinda Gates Foundation (BMGF), The Biomedical Advanced Research and Development Authority (BARDA), and the Wellcome Trust hosted a virtual workshop entitled “Mucosal Vaccines for SARS-CoV-2: Scientific Gaps and Opportunities.” …”
Get full text

A latent trajectory analysis of young sexual and gender minorities’ adherence to three rectal microbicide placebo formulations (MTN-035; a randomized crossover trial) by Seul Ki Choi, José Bauermeister, Ryan C. Tingler, Sherri Johnson, Nicole Macagna, Ken Ho, Craig Hoesley, Albert Liu, Noel Kayange, Thesla Palanee-Phillips, Suwat Chariyalertsak, Pedro Gonzales, Jeanna M. Piper, MTN-035 Protocol Team

Get full text

Application of a Sanger-Based External Quality Assurance Strategy for the Transition of HIV-1 Drug Resistance Assays to Next Generation Sequencing by Cheryl Jennings, Neil T. Parkin, Daniel J. Zaccaro, Rupert Capina, Paul Sandstrom, Hezhao Ji, Donald J. Brambilla, James W. Bremer

“…The National Institute of Allergy and Infectious Diseases (NIAID) Virology Quality Assurance (VQA) established a robust proficiency testing program for Sanger sequencing (SS)-based HIV-1 drug resistance (HIVDR) testing in 2001. …”
Get full text

Co-infection of Leishmania infantum and a Crithidia-related species in a case of refractory relapsed visceral leishmaniasis with non-ulcerated cutaneous manifestation in Brazil by Luana Aparecida Rogerio, Talita Yuri Takahashi, Luria Cardoso, Nayore Tamie Takamiya, Enaldo Vieira de Melo, Amelia Ribeiro de Jesus, Fabricia Alvisi de Oliveira, Sarah Forrester, Daniel C. Jeffares, João Santana da Silva, José Marcos Ribeiro, Roque Pacheco Almeida, Sandra Regina Maruyama

Get full text

Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination by Minassian, AM, Silk, SE, Barrett, JR, Nielsen, CM, Miura, K, Diouf, A, Loos, C, Fallon, JK, Michell, AR, White, MT, Edwards, NJ, Poulton, ID, Mitton, CH, Payne, RO, Marks, M, Maxwell-Scott, H, Querol-Rubiera, A, Bisnauthsing, K, Batra, R, Ogrina, T, Brendish, NJ, Themistocleous, Y, Rawlinson, TA, Ellis, KJ, Quinkert, D, Baker, M, Lopez Ramon, R, Ramos Lopez, F, Barfod, L, Folegatti, PM, Silman, D, Datoo, M, Taylor, IJ, Jin, J, Pulido, D, Douglas, AD, de Jongh, WA, Smith, R, Berrie, E, Noe, AR, Diggs, CL, Soisson, LA, Ashfield, R, Faust, SN, Goodman, AL, Lawrie, AM, Nugent, FL, Alter, G, Long, CA, Draper, SJ

“…</p> <p><strong>Funding:</strong> This study was supported by USAID, UK MRC, Wellcome Trust, NIAID, and the NIHR Oxford-BRC.</p>…”

Protection of calves by a prefusion-stabilized bovine RSV F vaccine by Baoshan Zhang, Lei Chen, Chiara Silacci, Michelle Thom, Jeffrey C. Boyington, Aliaksandr Druz, M. Gordon Joyce, Efrain Guzman, Wing- Pui Kong, Yen-Ting Lai, Guillaume B. E. Stewart-Jones, Yaroslav Tsybovsky, Yongping Yang, Tongqing Zhou, Ulrich Baxa, John R. Mascola, Davide Corti, Antonio Lanzavecchia, Geraldine Taylor, Peter D. Kwong

“…An international team comprising Geraldine Taylor, The Pirbright Institute, UK, Davide Corti and Antonio Lanzavecchia, Institute for Research in Biomedicine, Switzerland, and Peter Kwong, Vaccine Research Center, NIAID, NIH, United States, and their teams constructed the subunit vaccine from an engineered bRSVfusion (F) glycoprotein that protected challenged calves by generating a highly protective immune response. …”
Get full text